CorMedix Inc. (CRMD)

CorMedix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	163.06	-17.93	-46.34	-29.7	-28.21
Depreciation & Amortization	15.39	0.46	0.21	0.21	0.18
Stock-Based Compensation	13.83	6.13	5.49	4.07	5.04
Other Adjustments	-24.49	0.14	-	-	-
Change in Receivables	-90.92	-51.79	-	0.04	-0.04
Changes in Inventories	-3.48	-5.49	-2.11	0	0.15
Changes in Accounts Payable	3.33	-2.56	2.08	-0.01	1.08
Changes in Accrued Expenses	100.77	22.99	3	0.96	0.09
Changes in Other Operating Activities	-2.43	-2.55	-0.74	0.07	0.56
Operating Cash Flow	175.05	-50.62	-38.41	-24.36	-21.16
Capital Expenditures	-2.26	-0.12	-0.33	-0.22	-1.43
Purchases of Investments	-52.95	-26.77	-77.08	-31.14	-15.29
Proceeds from Sale of Investments	55.29	48.12	60.35	27.65	7.58
Payments for Business Acquisitions	-308.51	-	-	-	-
Investing Cash Flow	-308.43	21.23	-17.06	-3.71	-9.13
Long-Term Debt Issued	150	-	-	-	-
Net Long-Term Debt Issued (Repaid)	150	-	-	-	-
Issuance of Common Stock	96.55	26.61	56.12	17.9	41.76
Repurchase of Common Stock	-1.99	-0.29	-0.2	-	-
Net Common Stock Issued (Repurchased)	94.56	26.32	55.92	17.9	41.76
Other Financing Activities	-6.11	-	-	-	-
Financing Cash Flow	238.45	26.32	55.92	17.9	41.76
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0	-	0	-0.01	-0.01
Net Cash Flow	105.07	-3.07	0.45	-10.18	11.45
Free Cash Flow	172.79	-50.73	-38.74	-24.58	-22.58
FCF Margin	55.43%	-116.70%	-	-37573.53%	-11826.24%
Free Cash Flow Per Share	2.15	-0.86	-0.76	-0.61	-0.60
Levered Free Cash Flow	424.37	-5.21	-44.23	-28.69	-27.58
Unlevered Free Cash Flow	248.41	-11.25	-46.85	-29.02	-27.56

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q